Anti-MLLT3 monoclonal antibody Made to order

The emerging role of plant biostimulants in enhancing nutrient efficiency is important for maintaining soil fertility under sub-optimal nutrient regimens. We aimed to elucidate the morpho-physiological and biochemical effects as well as mineral composition changes of greenhouse jute (Corchorus olitorius L.) treated with a commercial vegetal-derived biostimulant from a tropical plant extract (PE; Auxym((R)), Italpollina, Rivoli Veronese, Italy). Plants were sprayed in weekly intervals with a solution containing 2 mLL(-1) PE. Jute plants were supplied with three nutrient solution concentrations: full-, half-, and quarter-strength. Decreasing macronutrient concentrations in the nutrient solution (NS), especially at quarter-strength, triggered a decrease in several morphological (plant height, leaf number, and dry biomass) and physiological (net CO2 assimilation rate (A(CO2)) and SPAD (Soil Plant Analysis Development) index) parameters. PE application triggered specific ameliorative effects in terms of fresh yield at both half- and quarter-strength nutrient solution (15.5% and 29.5%, respectively). This was associated with an enhancement in A(CO2), SPAD index, and especially the nutritional status (high nitrate, K, and Mg contents, and low Na content). The foliar application of PE, strongly increased chlorophyll b content, enhancing jute plant adaptation to fluctuating light and therefore the efficiency of photosynthesis, positively affecting starch, soluble proteins, and total amino acids content but only when jute plants were irrigated with full-strength NS, compared to the respective control treatment. At lower nutrient strength, PE reprogrammed the nitrogen distribution, allowing its remobilization from glutamate, which was quantitatively the major amino acid under lower nutrient strength, but not from chlorophylls, thus maintaining efficient photosynthesis. We confirmed that PE Auxym((R)) acts in a balanced manner on the main metabolic pathways of the plant, regulating the uptake and transport of mineral nutrients and protein synthesis, increasing the accumulation of essential amino acids under full nutritive solutions, and re-distributing nitrogen from amino acids to allow leaf growth and expansion even under sub-optimal nutrient conditions. Overall, the use of natural plant biostimulants may be a potential solution in low-input conditions, where environmental constraints and restricted use of fertilizers may affect potential crop productivity.

The prognosis for infants with acute lymphoblastic leukemia (ALL), particularly those with KMT2A gene rearrangement (KMT2A-r), is dismal. Continuous efforts have been made in Japan to investigate the role of hematopoietic stem cell transplantation (HSCT) for infants with KMT2A-r ALL, but improvement in outcome was modest. In the Japanese Pediatric Leukemia/Lymphoma Study Group MLL-10 trial, infants with ALL were stratified into 3 risk groups (low risk [LR], intermediate risk [IR], and high risk [HR]) according to KMT2A status, age, and presence of central nervous system leukemia. Children's Oncology Group AALL0631 modified chemotherapy with the addition of high-dose cytarabine in early intensification was introduced to KMT2A-r patients, and the option of HSCT was restricted to HR patients only. The role of minimal residual disease (MRD) was also evaluated. Ninety eligible infants were stratified into LR (n=15), IR (n=19), or HR (n=56) risk groups. The 3-year event-free survival (EFS) rate for patients with KMT2A-r ALL (IR + HR) was 66.2% (standard error [SE], 5.6%), and for those with germline KMT2A (KMT2A-g) ALL (LR), the 3-year EFS rate was 93.3% (SE, 6.4%). The 3-year EFS rate was 94.4% (SE, 5.4%) for IR patients and 56.6% (SE, 6.8%) for HR patients. In multivariable analysis, female sex and MRD >= 0.01% at the end of early consolidation were significant factors for poor prognosis. Risk stratification and introduction of intensive chemotherapy in this study were effective and were able to eliminate HSCT for a subset of infants with KMT2A-r ALL. Early clearance of MRD seems to have translated into favorable outcomes and should be incorporated into risk stratifications in future trials.